The composition and function of the plasma membrane is maintained by a complex intracellular traffic moving cell surface glycoproteins between organelles. This requires the recognition and sorting of different classes of proteins, not only during biosynthesis, but also during redistributive processes, such as the internalization and recycling of receptors during receptor-mediated endocytosis, transcytosis, or during the down-regulation of hormone receptors. Disease can result from the failure of any one of these processes, or from its subversion for use by a pathogen such as a virus. The focus of the work described in this application is to determine the molecular details of post-Golgi sorting events. By establishing the details of sorting events for a few, well- understood proteins such as the influenza virus hemagglutinin and polyimmunoglobulin receptor, we intend to provide the basis for a comparison of the sorting events that occur in other cell types involving other proteins. Once the relationship between the sorting of different proteins in different cell types is understood, it may be possible to use this information for diagnostic purposes. Studies in vitro of cell types easily isolated from human patients might be used to learn about disease processes in organs for which biopsy material is limiting, difficult to isolate, or the cells difficult to maintain in culture. Experiments proposed in this application will test the hypothesis that transmembrane proteins contain hierarchies of sorting signals that allow them to be transported and localized to different destinations in different cell types. We will investigate potential apical sorting information in the transmembrane segments of a number of proteins for the purpose of establishing a consensus sequence for this type of sorting signal. We propose to identify proteins that bind to sorting signals and to determine the role of glycosphingolipid-enriched membranes in the sorting of the influenza virus hemagglutinin and other proteins sorted to the apical surface of epithelial cells or axons of neurons.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM037547-15
Application #
6329674
Study Section
Pathobiochemistry Study Section (PBC)
Program Officer
Marino, Pamela
Project Start
1986-12-01
Project End
2002-11-30
Budget Start
2000-12-01
Budget End
2001-11-30
Support Year
15
Fiscal Year
2001
Total Cost
$278,923
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Siu, Ka Yu; Yu, Mei Kuen; Wu, Xinggang et al. (2011) The non-catalytic carboxyl-terminal domain of ARFGAP1 regulates actin cytoskeleton reorganization by antagonizing the activation of Rac1. PLoS One 6:e18458
Shvartsman, Dmitry E; Kotler, Mariana; Tall, Renee D et al. (2003) Differently anchored influenza hemagglutinin mutants display distinct interaction dynamics with mutual rafts. J Cell Biol 163:879-88
Padron, David; Wang, Ying Jie; Yamamoto, Masaya et al. (2003) Phosphatidylinositol phosphate 5-kinase Ibeta recruits AP-2 to the plasma membrane and regulates rates of constitutive endocytosis. J Cell Biol 162:693-701
Tall, Renee D; Alonso, Miguel A; Roth, Michael G (2003) Features of influenza HA required for apical sorting differ from those required for association with DRMs or MAL. Traffic 4:838-49
Wang, Ying Jie; Wang, Jing; Sun, Hui Qiao et al. (2003) Phosphatidylinositol 4 phosphate regulates targeting of clathrin adaptor AP-1 complexes to the Golgi. Cell 114:299-310
Yu, Sidney; Roth, Michael G (2002) Casein kinase I regulates membrane binding by ARF GAP1. Mol Biol Cell 13:2559-70
Keren, T; Roth, M G; Henis, Y I (2001) Internalization-competent influenza hemagglutinin mutants form complexes with clathrin-deficient multivalent AP-2 oligomers in live cells. J Biol Chem 276:28356-63
Lewis, C M; Latham, K; Roth, M G (2000) A screen of random sequences for those that alter the trafficking of the influenza virus hemagglutinin in vivo. Traffic 1:282-90
Melikyan, G B; Markosyan, R M; Roth, M G et al. (2000) A point mutation in the transmembrane domain of the hemagglutinin of influenza virus stabilizes a hemifusion intermediate that can transit to fusion. Mol Biol Cell 11:3765-75
Brown, C M; Roth, M G; Henis, Y I et al. (1999) An internalization-competent influenza hemagglutinin mutant causes the redistribution of AP-2 to existing coated pits and is colocalized with AP-2 in clathrin free clusters. Biochemistry 38:15166-73

Showing the most recent 10 out of 40 publications